Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial

Autor:	Mecinaj, Albulena, Gulati, Geeta, Heck, Siri Lagethon, Holte, Espen, Fagerland, Morten Wang, Larsen, Alf Inge, Blix, Egil Støre, Geisler, Jürgen, Wethal, Torgeir, Omland, Torbjørn
Databáze:	NORA (Norwegian Open Research Archive)
Externí odkaz:	https://hdl.handle.net/11250/2978886 Zobrazit plný text záznamu